Patents by Inventor Fabiana Kimie Kashiwabuchi

Fabiana Kimie Kashiwabuchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10471172
    Abstract: Ophthalmic suture materials made from biocompatible and biodegradable polymers with high tensile strength for use in drug delivery, methods of making them, and method of using them for ocular surgery and repair have been developed. The suture materials are made from a combination of a biodegradable, biocompatible polymer and a hydrophilic biocompatible polymer. In a preferred embodiment the suture materials are made from a poly(hydroxyl acid) such as poly(1-lactic acid) and a polyalkylene oxide such as poly(ethylene glycol) or a polyalkylene oxide block copolymer. The sutures entrap (e.g., encapsulate) one or more therapeutic, prophylactic or diagnostic agents and provide prolonged release over a period of at least a week, preferably a month.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: November 12, 2019
    Assignee: The Johns Hopkins University
    Inventors: Fabiana Kimie Kashiwabuchi, Justin Hanes, Hai-Quan Mao, Peter John McDonnell, Qingguo Xu, Shuming Zhang, Kunal S. Parikh
  • Publication number: 20170087271
    Abstract: Ophthalmic suture materials made from biocompatible and biodegradable polymers with high tensile strength for use in drug delivery, methods of making them, and method of using them for ocular surgery and repair have been developed. The suture materials are made from a combination of a biodegradable, biocompatible polymer and a hydrophilic biocompatible polymer. In a preferred embodiment the suture materials are made from a poly(hydroxyl acid) such as poly(1-lactic acid) and a polyalkylene oxide such as poly(ethylene glycol) or a polyalkylene oxide block copolymer. The sutures entrap (e.g., encapsulate) one or more therapeutic, prophylactic or diagnostic agents and provide prolonged release over a period of at least a week, preferably a month.
    Type: Application
    Filed: December 12, 2016
    Publication date: March 30, 2017
    Inventors: Fabiana Kimie Kashiwabuchi, Justin Hanes, Hai-Quan Mao, Peter John McDonnell, Qingguo Xu, Shuming Zhang, Kunal S. Parikh
  • Patent number: 9533068
    Abstract: Ophthalmic suture materials made from biocompatible and biodegradable polymers with high tensile strength for use in drug delivery, methods of making them, and method of using them for ocular surgery and repair have been developed. The suture materials are made from a combination of a biodegradable, biocompatible polymer and a hydrophilic biocompatible polymer. In a preferred embodiment the suture materials are made from a poly(hydroxyl acid) such as poly(l-lactic acid) and a polyalkylene oxide such as poly(ethylene glycol) or a polyalkylene oxide block copolymer. The sutures entrap (e.g., encapsulate) one or more therapeutic, prophylactic or diagnostic agents and provide prolonged release over a period of at least a week, preferably a month.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: January 3, 2017
    Assignee: The Johns Hopkins University
    Inventors: Fabiana Kimie Kashiwabuchi, Justin Hanes, Hai-Quan Mao, Peter John McDonnell, Qingguo Xu, Shuming Zhang
  • Publication number: 20130296933
    Abstract: Ophthalmic suture materials made from biocompatible and biodegradable polymers with high tensile strength for use in drug delivery, methods of making them, and method of using them for ocular surgery and repair have been developed. The suture materials are made from a combination of a biodegradable, biocompatible polymer and a hydrophilic biocompatible polymer. In a preferred embodiment the suture materials are made from a poly(hydroxyl acid) such as poly(l-lactic acid) and a polyalkylene oxide such as poly(ethylene glycol) or a polyalkylene oxide block copolymer. The sutures entrap (e.g., encapsulate) one or more therapeutic, prophylactic or diagnostic agents and provide prolonged release over a period of at least a week, preferably a month.
    Type: Application
    Filed: May 6, 2013
    Publication date: November 7, 2013
    Applicant: The Johns Hopkins University
    Inventors: Fabiana Kimie Kashiwabuchi, Justin Hanes, Hai-Quan Mao, Peter John McDonnell, Himatkumar Patel, Murilo W. Rodrigues, Jesus Vidauri-Martinez, Qingguo Xu, Shuming Zhang